Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added new dates (2025-10-08, 2025-11-30, 2025-10-07) and removed older dates (2025-09-10, 2025-08-30, 2025-09-08). This indicates updated timing information but no changes to core content or pricing.
    Difference
    0.4%
    Check dated 2025-10-13T08:36:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T05:36:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Introduces version v3.1.0 and removes two disease topic entries (Mammary Neoplasms, Animal; Animal Diseases) indicating a reorganization and an updated release.
    Difference
    0.2%
    Check dated 2025-09-29T03:08:17.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    - The page now reflects Revision v3.0.2 with September 2025 dates and an estimated last update. - Older content (v3.0.1, May 2025 dates, 'Back to Top', and unqualified 'Last Update Posted') was removed.
    Difference
    1%
    Check dated 2025-09-14T19:21:50.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T15:41:10.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has undergone significant changes in its facility and location information, with the addition of specific disease categories and the drug palbociclib, while previous location details and certain drug classifications have been removed.
    Difference
    2%
    Check dated 2025-08-31T11:55:28.000Z thumbnail image

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.